Exosomes derived from lung cancer cells activate the PI3K/Akt pathway, transfect si-FOXD3-AS1, or using the PI3K inhibitor LY294002 could reverse activation of the PI3K/Akt axis induced by exosomes. This evidence concerns the gene FOXD3 and lung cancer.